Replies to post #7219 on Calypte Biomedical Corp (fka CBMC)

[sellhigh]

poor goldie keeps thinking the facts will change. Here is another one for you goldie. Calypte's own mgt said, when it was introduced, that the BED test was a niche market test. As in not a mass market test. As in "never enough sales to float this boat".